Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Acta Paediatr ; 99(4): 556-62, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20096031

ABSTRACT

AIM: The aim of this study was to describe first-year growth among very low birth weight infants and the effect of growth restriction at hospital discharge on first year growth. METHOD: Anthropometric measures and background information for 118 very low birth weight infants were collected from medical records. Z-scores were calculated based on recent Norwegian growth references. RESULTS: Significant catch-up growth for weight and length was observed during the first year with mean z-score change (SD) of 0.40 (1.05) and 1.01 (1.25) respectively. However, the very low birth weight infants remained lighter and shorter than full-term peers until 12 months corrected age with mean z-score of -0.93 (1.09) and -0.48 (1.06) respectively. Head circumference followed a normal growth pattern after 2 months. Infants discharged from hospital as growth restricted had increased catch-up in weight and length, but remained smaller than infants not subjected to early growth restriction and full-term peers. Multiple regression showed that weight below the 10th percentile at discharge is important for weight and length during the first year of life. CONCLUSION: Very low birth weight infants showed catch-up growth during the first year, but their weight and length remained less than full-term peers. Growth deficiencies were more pronounced among infants subjected to early growth restriction, despite increased catch-up growth.


Subject(s)
Infant, Premature/growth & development , Infant, Very Low Birth Weight/growth & development , Anthropometry , Female , Head/growth & development , Humans , Infant , Infant, Newborn , Male , Medical Records , Norway , Retrospective Studies , Weight Gain
2.
Patient Educ Couns ; 102(5): 1005-1012, 2019 05.
Article in English | MEDLINE | ID: mdl-30606641

ABSTRACT

OBJECTIVES: Familial hypercholesterolemia (FH) is a hereditary and usually asymptomatic condition characterized by elevated blood cholesterol and increased risk of premature cardiovascular disease. It is treated with dietary modifications and lipid lowering drugs. The objective was to learn about young FH patients' perceptions and choices regarding treatment. METHODS: Data were collected through in-depth interviews with 24 patients (ages 16-35), and analysed according to Grounded Theory. RESULTS: The findings are presented as theoretical concepts describing the participants' way of handling their condition. The core category was identified as "Thoughts of consequences vs. Postponing thoughts of consequences", which could be described through the following subcategories: 1. Normalising the condition, 2. Belittling of treatment vs. Committed to treatment and 3. Trust in advice vs. Avoid unnecessary interference. The participants' position regarding these categories was described to affect motivation and challenges with treatment. CONCLUSIONS: Participants who postpone the thoughts of consequences, belittle the treatment and avoid unnecessary interference represent a challenge to health care practitioners. PRACTICAL IMPLICATIONS: Practitioners should explore aspects such as thoughts of consequences, view of treatment and the feeling of interference to be able to better understand illness behaviour, adjust their communication and hopefully improve adherence.


Subject(s)
Attitude to Health , Cardiovascular Diseases/genetics , Family/psychology , Health Knowledge, Attitudes, Practice , Hyperlipidemia, Familial Combined/psychology , Adolescent , Adult , Communication , Female , Genetic Predisposition to Disease , Humans , Hyperlipidemia, Familial Combined/diagnosis , Hyperlipidemia, Familial Combined/therapy , Interviews as Topic , Qualitative Research , Young Adult
3.
Atherosclerosis ; 252: 21-27, 2016 09.
Article in English | MEDLINE | ID: mdl-27494447

ABSTRACT

BACKGROUND AND AIMS: Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C). Guidelines recommend cholesterol-lowering medication from 8 to 10 years of age and dietary recommendations. Little is known about the diet of FH children and the effect of dietary counseling. The aim of the study was to describe the diet of FH children with respect to fat quality, and to investigate if dietary counseling improved lipid profile. METHODS: Fifty-four FH children (5-18 years) were included in the study and dietary intake was recorded with a pre-coded food diary for four days. Information about plasma lipid levels was obtained. RESULTS: Median intake of total fat, monounsaturated fat, polyunsaturated fat (PUFA) and saturated fat (SFA) was 30.8, 10.4, 5.9 and 12.0 E %, respectively. Among non-statin treated FH children, SFA intake was significantly correlated with TC, LDL-C and apolipoprotein (apo) B (rsp = 0.55; p = 0.004, rsp = 0.46; p = 0.02, and rsp = 0.45; p = 0.02, respectively), and PUFA/SFA ratio significantly inversely correlated with TC (rsp = -0.42; p = 0.03). Compared to the first visit, non-statin and non-plant sterol treated FH children (n = 10) had significantly reduced levels of TC (p < 0.01), LDL-C (p = 0.01), high-density lipoprotein cholesterol (p = 0.02), apo B (p = 0.05) and apo A-1 (p = 0.02) levels at a later visit. CONCLUSIONS: FH children had a higher intake of SFA than recommended and the SFA intake was positively correlated with plasma TC, LDL-C and apo B levels in FH children not using statins. Importantly, the plasma lipid profile was improved in FH children after dietary counseling where focus was on reducing intake of SFA and dietary cholesterol.


Subject(s)
Counseling , Diet , Hyperlipoproteinemia Type II/blood , Hyperlipoproteinemia Type II/diet therapy , Adolescent , Apolipoproteins B/blood , Child , Child, Preschool , Cholesterol/blood , Cholesterol, Dietary , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Diet Records , Dietary Fats/administration & dosage , Fatty Acids/adverse effects , Female , Follow-Up Studies , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Lipids/blood , Male , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL